A2 GUM Post-Market Effectiveness Study
Real-World Effectiveness Study of A2 Growing Up Milk (GUM) Among Young and Pre-School Age Toddlers in China
1 other identifier
interventional
387
1 country
1
Brief Summary
This is a post-market, real-life effectiveness study of A2 growing up milk on toddlers' gut comfort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2018
CompletedFirst Submitted
Initial submission to the registry
October 4, 2018
CompletedFirst Posted
Study publicly available on registry
October 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2019
CompletedJuly 7, 2020
July 1, 2020
6 months
October 4, 2018
July 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall digestive comfort
Toddler Gut Comfort score from parent-reported questionnaire (sub-scale range from 1 to 6, 10 sub-scales, total scores range from 10-60).
Baseline to Study Day 14
Secondary Outcomes (7)
Stool frequency
Baseline, Study Day 7, Study Day 14
Stool consistency
Baseline, Study Day 7, Study Day 14
Consumption of other milk products
Baseline, Study Day 7, Study Day 14
Child weight
Baseline, Study Day 7, Study Day 14
Child height
Baseline, Study Day 7, Study Day 14
- +2 more secondary outcomes
Study Arms (3)
A2 Growing Up Milk
EXPERIMENTALTraditional non-A2 milk
NO INTERVENTIONOther Growing Up Milk
ACTIVE COMPARATORInterventions
Commercially available toddler milk
Eligibility Criteria
You may qualify if:
- Having obtained his / her parents' (or his or her legally accepted guardian written informed consent and having evidence of personally signed and dated informed consent document indicating that the child's parent(s) / legal guardian has been informed of all pertinent aspects of the study.
- Children 12 - 36 months of age at enrolment.
- Children who have been born full-term (≥ 37 completed weeks of gestation) and having a birth weight ≥ 2.5 kg and ≤ 4.5 kg.
- Children who are habitually consuming some cow's milk, other traditional milks (including non-A2 GUMs, kids' milk, white milk, flavored milk) and/or dairy or non-dairy alternative milks (such as those sourced from goats, sheep, soy, rice, coconut, and nut).
- Child's parent(s) / guardian is of legal age of consent, has sufficient command of Chinese (Mandarin) language to complete the informed consent and other study documents, is willing and able to fulfill the requirements of the study protocol.
You may not qualify if:
- Chronic infectious, metabolic, genetic illness or other disease including any condition that impacts feeding or may impact outcome measures.
- Known and diagnosed cow's milk protein allergy.
- Children currently using or having ever used specialty infant formula and/or GUMs such as hypoallergenic (HA), lactose-free, or anti-regurgitation formulas.
- Children who have known cognitive and developmental disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Reproductive and Child Health, Peking University
Beijing, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2018
First Posted
October 5, 2018
Study Start
September 15, 2018
Primary Completion
February 28, 2019
Study Completion
March 31, 2019
Last Updated
July 7, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share